AnalystsManeka MirchandaneyManeka Mirchandaney's Stock Forecasts
AnalystsManeka Mirchandaney
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4309 out of 4870 analysts
Average Return
-28.64%
Win Rate
30%3 out of 10
Risk vs Reward
Poor
Good
Maneka Mirchandaney's 5 best and worst ratings
Maneka Mirchandaney Analyst Color
Get additional color on Maneka Mirchandaney's coverage of popular stocks
Maneka Mirchandaney's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals IncCRNX | 2 | Buy | $48.00 | N/A | Maintains | 2 years ago |
Mink Therapeutics IncINKT | 2 | Buy | $3.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 2 | Buy | $175.00 | N/A | Upgrades | 2 years ago |
Incyte CorpINCY | 1 | Hold | $78.00 | N/A | Downgrades | 3 years ago |
Neuphoria Therapeutics IncNEUP | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 3 years ago |
Viridian Therapeutics IncVRDN | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 4 years ago |
Finch Therapeutics Group IncFNCH | 1 | Buy | $1,020.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Buy | $102.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.